Skip to main content Help with accessibility Skip to main navigation

RISANKIZUMAB (Skyrizi®▼) for Crohn’s disease

CCG Approval Status:

Date Added: 26 - Mar - 2024

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of RISANKIZUMAB (Skyrizi®▼), by specialists only, for previously treated moderately to severely active Crohn's disease in accordance with NICE TA888.

NHS Cheshire and Merseyside APPROVED